Pluristem Therapeutics, Inc. (PSTI) Prepares Presentation for Italian CREM Workshop Focused on Placental-Derived Cells
Pluristem Therapeutics Inc., a bio-therapeutics company focused on the commercialization of unrelated donor-patient cell therapy products for a variety of disorders, announced that its Senior Scientist, Racheli Ofir, Ph.D., has been invited by the Centro di Ricerca E. Menni (CREM), Fondazione Poliambulanza, Brescia, Italy, to present at a workshop titled “Placenta-Derived Cells for Treatment of Inflammatory Diseases: Moving Toward Clinical Applications” on March 13, 2009. Zami Aberman, Chairman, President and CEO of Pluristem, commented, “The research and medical communities are very interested in the placenta as a superior source for cell therapy. This entire workshop is devoted to studies performed…